Malignant Lung Neoplasm — Trials

Malignant Lung Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,127 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,433
Ph III recruiting: 179
Growth YoY: +7.6%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%
Trials / 1,000 deaths: 20.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,491)

clinicaltrialsPublishedShowing 1,001–1,050 of 1,696 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05611450	Mobile Health Application of Disease Self-Management in Non-Small Cell Lung Cancer Patients During Targeted Therapy	unknown	N/A	108	Chang Gung Memorial HospitalOTHER	0	Nov 10, 2022	clinicaltrials
NCT05319457	Testing Radon Com Methods: Clinical Trial Smartphone App vs Print Brochures	completed	N/A	130	University of North DakotaOTHER	1	Nov 2, 2022	clinicaltrials